β-nicotinamide mononucleotide
Showing 1 - 25 of 1,215
Binge Drinking, Liver Injury, Nutritional Supplementation Trial in Hangzhou (ß-nicotinamide Mononucleotide, Maltodextrin)
Not yet recruiting
- Binge Drinking
- +3 more
- β-nicotinamide Mononucleotide
- Maltodextrin
-
Hangzhou, Zhejiang, ChinaZhejiang Chinese Medical University
May 19, 2023
Healthy Trial (Investigational Product - MIB 626, Placebo, Standardized, progressive, high intensity, multidimensional exercise)
Not yet recruiting
- Healthy
- Investigational Product - MIB 626
- +3 more
- (no location specified)
Jun 1, 2023
Hypertension Trial in Guangzhou (Nicotinamide mononucleotide supplied as 400mg capsule, Lifestyle modification)
Recruiting
- Hypertension
- Nicotinamide mononucleotide supplied as 400mg capsule
- Lifestyle modification
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital,Sun Yat-sen University
Jan 17, 2022
Healthy Volunteers Trial in Dijon (Nicotinamide mononucleotide (NMN-C))
Completed
- Healthy Volunteers
- Nicotinamide mononucleotide (NMN-C)
-
Dijon, FranceBiomed 21
Jan 25, 2023
Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)
Recruiting
- Healthy
- nicotinamide riboside
- nicotinamide mononucleotide
-
Bergen, Vestland, NorwayHaukeland University Hospital
Jan 25, 2023
Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)
Not yet recruiting
- Postoperative Prevention of Tumor
- Oral NMN combined with DC cell vaccine
-
Shanghai, Shanghai, ChinaShanghai Mengchao Cancer Hospital
Sep 6, 2023
Polycystic Ovary Syndrome Trial in Beijing (NMN intervention, Placebo)
Recruiting
- Polycystic Ovary Syndrome
- NMN intervention
- Placebo
-
Beijing, ChinaPeking University Third Hospital
Jun 20, 2022
Diminished Ovarian Reserve, Premature Ovarian Insufficiency Trial in Beijing (NMN intervention, Placebo)
Not yet recruiting
- Diminished Ovarian Reserve
- Premature Ovarian Insufficiency
- NMN intervention
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Aug 2, 2022
Healthy Volunteers Trial in Toronto (Nicotinamide mononucleotide (NMN-C))
Active, not recruiting
- Healthy Volunteers
- Nicotinamide mononucleotide (NMN-C)
-
Toronto, Ontario, CanadaVitalabs Clinic
May 31, 2022
Physical Activity, Muscle Recovery Trial in Dijon (Nicotinamide mononucleotide, Placebo)
Recruiting
- Physical Activity
- Muscle Recovery
- Nicotinamide mononucleotide
- Placebo
-
Dijon, FranceCEN Nutriment
May 31, 2022
COVID-19 Infection Trial in India (Nicotinamide Mononucleotide, Nicotinamide Mononucleotide with L-Leucine, Placebo)
Recruiting
- COVID-19 Infection
- Nicotinamide Mononucleotide
- +2 more
-
Vadodara, Gujarat, India
- +11 more
Feb 16, 2022
Glucose Metabolism Disorders Trial in Saint Louis (NMN supplement, Placebo)
Completed
- Glucose Metabolism Disorders
- NMN supplement
- Placebo
-
Saint Louis, MissouriWashington University School of Medicine
Jul 13, 2021
Diabetic Neuropathy Peripheral Trial in Baltimore (Niagen, Placebo)
Suspended
- Diabetic Neuropathy Peripheral
- Niagen
- Placebo
-
Baltimore, MarylandUniversity of Maryland
Mar 24, 2022
Glucose Metabolism Disorders Trial in Saint Louis (Placebo, Treatment)
Recruiting
- Glucose Metabolism Disorders
- Placebo
- Treatment
-
Saint Louis, MissouriWashington University School of Medicine
Dec 6, 2022
Aging Trial in Pune (Nicotinamide Mononucleotide, Placebo)
Completed
- Aging
- Nicotinamide Mononucleotide
- Placebo
-
Pune, Maharashtra, India
- +1 more
Sep 30, 2021
Aging Trial in Pune (NMN, Placebo)
Completed
- Aging
- NMN
- Placebo
-
Pune, Maharashtra, India
- +1 more
Mar 30, 2021
Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)
Recruiting
- Alzheimer's Disease (Incl Subtypes)
- Dementia
- MIB-626
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 11, 2022
Sickle Cell Disease Trial in Marseille (NUV001)
Not yet recruiting
- Sickle Cell Disease
- NUV001
-
Marseille, FranceAphm Hopital La Timone Adultes Sce Medecine Interne (Umap)
Mar 28, 2023
Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)
Not yet recruiting
- Type2diabetes
- Diabetic Kidney Disease
- Investigational Product - MIB 626
- Placebo
- (no location specified)
Mar 6, 2023
Alzheimer, Parkinson Disease Trial in Antalya, Istanbul (Metabolic Cofactor Supplementation, Sorbitol)
Completed
- Alzheimer Disease
- Parkinson Disease
- Metabolic Cofactor Supplementation
- Sorbitol
-
Antalya, Turkey
- +1 more
Aug 5, 2022
AKI Trial in Rochester (Nicotinamide Riboside + Pterostilbene, Placebo)
Recruiting
- AKI
- Nicotinamide Riboside + Pterostilbene
- Placebo
-
Rochester, MinnesotaMayo Clinic
Feb 9, 2022
Hypertension, Aging Trial in Boulder (Nicotinamide riboside, Placebo)
Recruiting
- Hypertension
- Aging
- Nicotinamide riboside
- Placebo
-
Boulder, ColoradoIntegrative Physiology of Aging Laboratory
Feb 14, 2022
Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors
Recruiting
- Glioblastoma Multiforme
- Surgical removal of the GBM tumor
- d4-NAM infusion
-
Orlando, FloridaAdventHealth Translational Research Institute
Sep 20, 2023
Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release
Recruiting
- Migraine Prophylaxis
- Nicotinic Acid 500 MG Extended Release Oral Tablet
- +2 more
-
Dhaka, BangladeshBSMMU
May 5, 2023